CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CARsgen Therapeutics Holdings Ltd. announced a shareholding increase by YIJIE Biotech, a substantial shareholder, who has now acquired additional shares, raising their stake from approximately 37.45% to 37.78%. Moreover, the company has utilized its repurchase mandate to buy back 0.69% of its total issued shares using non-IPO funds, highlighting the shareholder’s confidence and the company’s commitment to sustaining its market value.
For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.